Krensavage Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $371K | Sell |
|
|||||
|
2024
Q2 | $8.25M | Sell |
|
|||||
|
2024
Q1 | $12M | Sell |
|
|||||
|
2023
Q4 | $41.5M | Hold |
|
|||||
|
2023
Q3 | $38.9M | Sell |
|
|||||
|
2023
Q2 | $42.5M | Sell |
|
|||||
|
2023
Q1 | $48.9M | Sell |
|
|||||
|
2022
Q4 | $43.4M | Sell |
|
|||||
|
2022
Q3 | $41.9M | Buy |
|
|||||
|
2022
Q2 | $35.7M | Sell |
|
|||||
|
2022
Q1 | $46.7M | Sell |
|
|||||
|
2021
Q4 | $43.6M | Sell |
|
|||||
|
2021
Q3 | $44.3M | Sell |
|
|||||
|
2021
Q2 | $45.9M | Sell |
|
|||||
|
2021
Q1 | $39.1M | Buy |
|
|||||
|
2020
Q4 | $39.7M | Sell |
|
|||||
|
2020
Q3 | $46M | Buy |
|
|||||
|
2020
Q2 | $49.7M | Sell |
|
|||||
|
2020
Q1 | $42.4M | Sell |
|
|||||
|
2019
Q4 | $39.2M | Buy |
|